"Promising Early Test Suggests Potential Cure for ALS, Parkinson’s, and More"

Chinese scientists and clinicians are testing a potential new drug, "SNUG01," on a patient with ALS, showing promising results after six months of treatment, including slowed disease progression and improved response to electrical stimulation in the patient's lower limbs. The drug, a gene therapy, has also shown potential for treating Alzheimer's and Parkinson's diseases. While the drug is still in early stages of testing, it has garnered attention for its potential to offer more effective treatment for ALS and other neurological disorders, with preparations underway for a clinical trial involving six patients.